Pappas Capital
Venture Capital
Active
Durham, United States
31
52M
26
1.03
2
0.16
8
- Stages of investment
- Areas of investment
Summary
Pappas Capital is the famous VC, which was founded in 1994. The main department of described VC is located in the Durham. The company was established in North America in United States.
The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Pappas Capital, startups are often financed by Fonds de solidaritu00e9 FTQ, Pappas Ventures, Go Capital. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Tekla Capital Management, RiverVest. In the next rounds fund is usually obtained by Venrock Healthcare Partners, Tekla Capital Management, RTW Investments LLC.
Among the most popular fund investment industries, there are Genetics, Health Care. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 3 of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CuraSen Therapeutics, 4D Molecular Therapeutics, Amplyx Pharmaceuticals.
Comparing to the other companies, this Pappas Capital performs on 11 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2019. The top activity for fund was in 2018. The common things for fund are deals in the range of 50 - 100 millions dollars.
Investor highlights
- Industry focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 200000000
- Fund raised date
- 2022-03-30
Analytics
- Total investments
- 31
- Lead investments
- 2
- Exits
- 8
- Rounds per year
- 1.03
- Follow on index
- 0.16
- Investments by industry
- Biotechnology (24)
- Health Care (12)
- Medical (12)
- Pharmaceutical (11)
- Therapeutics (8) Show 27 more
- Investments by region
-
- United States (23)
- Canada (2)
- China (2)
- Singapore (3)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 1.00
- Avg. company exit year
- 15
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Allievex | 23 Oct 2019 | Biotechnology | Early Stage Venture | United States, Massachusetts | |
| Enlaza Therapeutics | 30 Apr 2024 | Biotechnology, Health Care, Therapeutics, Biopharma | Early Stage Venture | 100M | United States, California, La Jolla |
| PocketEye | 01 Nov 2022 | Health Care | Seed | 68K | England, London, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.